Compound 14
Identifiers
- Canonical SMILES:
CCc1ccc2NC(=O)[C@@H](N([C@H](C(O)=O)c3ccc(Cl)cc3)C(=O)c2c1)c1ccc(Cl)cc1
- IUPAC name:
2-(4-chlorophenyl)-2-[3-(4-chlorophenyl)-7-ethyl-2,5-dioxo-1,3-dihydro-1,4-benzodiazepin-4-yl]acetic acid
- InChi:
InChI=1S/C25H20Cl2N2O4/c1-2-14-3-12-20-19(13-14)24(31)29(22(25(32)33)16-6-10-18(27)11-7-16)21(23(30)28-20)15-4-8-17(26)9-5-15/h3-13,21-22H,2H2,1H3,(H,28,30)(H,32,33)/t21-,22-/m0/s1
- InChiKey:
YIEASSPQFWICET-VXKWHMMOSA-N
External links
44390637 |
CHEMBL359740 |
23246659 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.82 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 482.08 g/mol | |||
HBA | 6 | |||
HBD | 2 | |||
HBA + HBD | 8 | |||
AlogP | 6.38 | |||
TPSA | 86.71 | |||
RB | 5 |